Navigation Links
New Implantable Device That Can Keep The Heart Ticking

People with a serious heart condition called nonischemic cardiomyopathy may improve their chances of survival if they have a device called a cardioverter-defibrillator implanted in their chests.//

Researchers, assigned about 460 patients with severe cardiomyopathy to receive either standard treatment, with drugs like ACE inhibitors and beta-blockers, or standard treatment plus an implanted defibrillator. A defibrillator is a device that regulates the heart rhythm like a pacemaker, but delivers an electrical jolt to reset the heart if that fails.

Results show those who got the defibrillator were significantly less likely to die. During the initial follow up, 40 people in the standard treatment group passed away, compared to 28 in the defibrillator group. After two years, the mortality rate was about 14 percent in the standard treatment group vs. about 8 percent in the defibrillator group. Significantly, sudden deaths from irregular heartbeats were reduced from 14 in the standard treatment group to just three in the defibrillator group.

Based on their findings researchers however say “the use of these devices should be considered on a case-by-case basis.”
'"/>




Page: 1

Related medicine news :

1. Implantable Contact Lens Found Safe and Effective
2. Making MRIs Safe for Patients With Implantable Heart Devices
3. Implantable devices to be powered by organosilicon compounds in the future
4. Combination therapy for patients treated with Implantable Cardioverter Defibrillator
5. New Implantable Cardioverter Defibrillators to avoid unnecessary shocks
6. First Implantable artificial heart gets FDA’s approva
7. Injection supports Heart Devices
8. New Heart-Screening Device ,An Accurate Predictor Of Heart Disease
9. Government Organisation Proposes Strict Guidelines For SubStandard Medical Devices
10. Withdrawal Notice Issued For Older Pacemakers Due To Malfunctioning of the Device
11. Making MRIs Safe for Patients With Implantable Heart Devices
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... , ... Many families have long-term insurance that covers care for a family ... for care if the client has a cognitive impairment diagnosis. , “What this ... often waived, so the benefits from their insurance start immediately,” said Mechell Vieira, owner ...
(Date:10/13/2017)... NY (PRWEB) , ... October 13, 2017 , ... Ellevate ... people in business to advocate for action towards gender equality at their inaugural Summit ... from around the globe, and reached a social audience of over 3 million. To ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Yisrayl Hawkins, ... week that explains one of the most popular and least understood books in the ... cryptic and puzzling descriptions that have baffled scholars for centuries. Many have tossed it ...
(Date:10/13/2017)... ... 2017 , ... Coveros, a leader in agile coaching services ... by the Center for Medicare and Medicaid Services (CMS). The Enterprise Agile Transformation ... Agile methodologies in a consistent and high value manner across CMS programs. Coveros ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: ... “America On The Brink” is the creation of published author, William Nowers. ... As a WWII veteran, he spent thirty years in the Navy. Following ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... PHILADELPHIA , Oct. 2, 2017 Halo Labs announces ... particle analysis system called the HORIZON at MIBio 2017 in ... analyzes subvisible and visible particulate matter in biopharmaceutical samples with unprecedented ... use of the novel technique Backgrounded Membrane Imaging. ... The HORIZON subvisible particle analysis system ...
(Date:9/27/2017)...  Commended for their devotion to personalized service, SMP Pharmacy ... one in the South Florida Business Journal,s 50 Fastest-Growing Companies, ... list, the national specialty pharmacy has found its niche.  To ... soon be honored by SFBJ as the 2017 Power Leader ... to receive his award in October, Bardisa said of the ...
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
Breaking Medicine Technology: